ProShare Advisors’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-13,245
| Closed | -$44K | – | 1758 |
|
|
2019
Q4 | $44K | Sell |
13,245
-3,271
| -20% | -$10.9K | ﹤0.01% | 1756 |
|
|
2019
Q3 | $50K | Buy |
16,516
+635
| +4% | +$1.92K | ﹤0.01% | 1601 |
|
|
2019
Q2 | $38K | Sell |
15,881
-2,587
| -14% | -$6.19K | ﹤0.01% | 1586 |
|
|
2019
Q1 | $69K | Buy |
18,468
+69
| +0.4% | +$258 | ﹤0.01% | 1600 |
|
|
2018
Q4 | $66K | Buy |
18,399
+1,771
| +11% | +$6.35K | ﹤0.01% | 1515 |
|
|
2018
Q3 | $95K | Sell |
16,628
-393
| -2% | -$2.25K | ﹤0.01% | 1687 |
|
|
2018
Q2 | $85K | Sell |
17,021
-341
| -2% | -$1.7K | ﹤0.01% | 1728 |
|
|
2018
Q1 | $89K | Sell |
17,362
-2,804
| -14% | -$14.4K | ﹤0.01% | 1645 |
|
|
2017
Q4 | $121K | Sell |
20,166
-914
| -4% | -$5.48K | ﹤0.01% | 1717 |
|
|
2017
Q3 | $117K | Buy |
21,080
+1,972
| +10% | +$10.9K | ﹤0.01% | 1318 |
|
|
2017
Q2 | $89K | Sell |
19,108
-741
| -4% | -$3.45K | ﹤0.01% | 1403 |
|
|
2017
Q1 | $98K | Sell |
19,849
-4,330
| -18% | -$21.4K | ﹤0.01% | 1513 |
|
|
2016
Q4 | $268K | Buy |
24,179
+4,842
| +25% | +$53.7K | ﹤0.01% | 1444 |
|
|
2016
Q3 | $179K | Sell |
19,337
-3,481
| -15% | -$32.2K | ﹤0.01% | 1359 |
|
|
2016
Q2 | $145K | Sell |
22,818
-2,405
| -10% | -$15.3K | ﹤0.01% | 1481 |
|
|
2016
Q1 | $164K | Sell |
25,223
-2,645
| -9% | -$17.2K | ﹤0.01% | 1452 |
|
|
2015
Q4 | $226K | Buy |
+27,868
| New | +$226K | ﹤0.01% | 1469 |
|